CHMP insists that generic drugs be market removed after fake trials
Digging its heels in over the summer, the EMA’s expert committee is still of the opinion that almost 100 generic medicines need to be removed from market – though eight have been granted clemency.
by christian bundgaard, translated by daniel pedersen
At summer meetings debating the issue of fake testing, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has chosen to stick to its guns – nearly 100 generic drugs will have to be removed from market, reports the Danish Medicines Agency.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
CHMP to remove 100 generic medicines from market
For subscribers
CHMP recommends approval of 12 drugs at September meeting
For subscribers
